文献速递淋巴瘤

PET驱动策略降低晚期霍奇金淋巴瘤患者性腺功能障碍风险

Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011).
PubMed 文献 · J Clin Oncol · 2021-06-22

AHL2011随机III期试验的子研究前瞻性分析了PET驱动策略对45岁以下晚期霍奇金淋巴瘤患者性腺功能与生育的影响。结果显示,PET驱动组女性早发性卵巢功能不全和低卵巢储备风险降低,男性精子参数恢复率更高、严重睾丸损伤风险更低且妊娠可能性更高,但女性妊娠率无显著差异。

要点

  • PET驱动组女性早发性卵巢功能不全风险显著降低(OR 0.20)。
  • PET驱动组男性严重睾丸损伤风险降低(OR 0.26),妊娠可能性更高(OR 3.7)。
  • 女性妊娠率两组无显著差异。

核心结论

  • PET驱动策略在晚期霍奇金淋巴瘤中降低性腺功能障碍和不育风险。

研究设计与样本

  • 前瞻性随机III期AHL2011试验子研究,纳入145例女性和424例男性,年龄<45岁,2011年5月19日至2014年4月29日入组。

主要发现

  • 女性:卵巢功能参数与年龄和烷化剂剂量相关,但妊娠率无显著差异。

关键数值与推荐

  • 早发性卵巢功能不全定义:FSH>24 IU/L。
  • 低卵巢储备定义:抗苗勒管激素(AMH)<0.5 ng/mL。

临床怎么用

  • 对年轻晚期霍奇金淋巴瘤患者,采用PET驱动策略可减少性腺毒性并保护生育潜能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The prospective, randomized AHL2011 trial demonstrated that the use of the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen (ABVD) after two cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPPescalated) in early responders on the basis of a positron emission tomography (PET)-driven strategy was safe and minimized toxicity compared with standard 6 BEACOPPescalated cycles. This substudy investigated the benefit of this strategy in gonadal function and fertility in patients under 45 years old. METHODS: Ovarian function was assessed by serum measurement of follicle-stimulating hormone (FSH), estradiol, and anti-müllerian hormone in women, and semen analysis, FSH, and testosterone levels were used to evaluate testicular function in men at baseline, end of treatment, and during 5 years of follow-up. RESULTS: A total of 145 women and 424 men, enrolled between May 19, 2011, and April 29, 2014, were included. The risk of premature ovarian insufficiency (FSH > 24 IU/L) and of having a low ovarian reserve (anti-müllerian hormone < 0.5 ng/mL) was reduced after treatment in the PET-driven group (odds ratio [OR], 0.20; 95% CI, 0.08 to 0.50; P = .001 and OR, 0.15; 95% CI, 0.04 to 0.56, P = .005, respectively). Both parameters were correlated with age and dose of alkylating agents. However, no significant differences were observed in terms of pregnancy rates. Men in the PET-driven group had a higher recovery rate of sperm parameters after treatment compared with the standard BEACOPPescalated group, as well as a lower risk of severe testicular damage (OR, 0.26; 95% CI, 0.13 to 0.5; P < .0001) and a higher likelihood of achieving pregnancy (OR, 3.7; 95% CI, 1.4 to 9.3; P = .004). CONCLUSION: Although both treatments affected ovarian reserve and spermatogenesis, the PET-driven strategy decreased the risk of gonadal dysfunction and infertility in advanced Hodgkin lymphoma.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Demeestere I, Racape J, Dechene J, et al. Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011). J Clin Oncol. 2021. PMID: 34156881. doi:10.1200/JCO.21.00068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。